Equity Research Associate - Oncology

LE001 Leerink Partners LLC; New York (NY); On-site; USD 110,000 - 170,000; Full time

Job summary

Leerink Partners in New York is seeking an Equity Research Associate in Oncology to join a growing team focused on cancer therapeutics. The role emphasizes public oncology biotech coverage and collaboration with physicians, scientists, and investors to inform investment ideas.

The candidate will analyze scientific data, build financial models, and monitor regulatory and competitive signals, with a strong emphasis on communicating well-supported conclusions to clients and internal stakeholders.

Qualifications

• Biotech equity research or related buy-side experience relevant to oncology.
• Experience in healthcare/life sciences or industry roles with a commercial focus.
• Familiarity with corporate/financial aspects of biotech and pharma.

Responsibilities

• Evaluate scientific, clinical, and financial factors affecting investment outcomes.
• Analyze oncology datasets (preclinical, translational, clinical).
• Build and maintain financial models and valuation frameworks.
• Support investment recommendations and research reports.
• Monitor trials, publications, patents, and regulatory updates.
• Track conferences, data presentations, and industry developments.
• Engage with physicians, management teams, and investors.
• Maintain records and follow-ups from interactions.
• Respond promptly to clinical, regulatory, and corporate developments.

Skills

Biotech equity research

Buyside experience

Healthcare consulting

Biotech industry roles

Investment banking exposure

Tools

Excel

Python

Job description

Job Title: Equity Research Associate – Oncology Reports to: Sr. Equity Research Analyst Department: Equity Research Location: New York Salary Range: $110,000-$170,000

Role Summary

The candidate will join a growing oncology research team focused on cancer therapeutics and emerging treatment modalities. The role centers on publicly traded oncology biotechnology companies, with awareness of relevant private companies and broader competitive, scientific, and strategic developments.

Responsibilities

Responsibilities include evaluating scientific, clinical, commercial, and financial factors that influence investment outcomes, while collaborating with physicians, scientists, management teams, and institutional investors.

• Analyze preclinical, translational, and clinical oncology datasets
• Build and maintain financial models and valuation frameworks
• Support investment recommendations and research reports
• Monitor clinical trials, publications, patents, regulatory updates, and competitive landscapes
• Track earnings, conferences, data presentations, and strategic developments across biotech and pharmaceutical companies
• Attend scientific and medical conferences
• Engage with physicians, key opinion leaders, management teams, and industry experts
• Maintain accurate records and follow-ups from company and investor interactions
• Respond quickly to clinical, regulatory, scientific, and corporate developments

Qualifications

We seek candidates with meaningful sell side equity research or similar experience who understand how organizations operate and execute in real-world environments. Purely academic backgrounds without corporate exposure are unlikely to be a fit. Relevant experience may include:

• Biotechnology or pharmaceutical equity research
• Buyside roles primarily focused on investing in biotechnology or pharmaceutical stocks at recognized institutions, hedge funds or VCs
• Healthcare/life sciences consulting
• Biotechnology or pharmaceutical industry roles, including business development, corporate strategy, or experience contributing to commercial corporate initiatives
• Biotechnology or pharmaceutical investment banking

Preferred Qualifications

• Strong understanding of oncology, drug development, and clinical trial design, with the ability to evaluate scientific and medical literature
• Strong analytical, quantitative, and financial modeling skills, including experience working with complex datasets
• Proficiency in Excel; familiarity with statistics, Python, or other analytical tools is a plus
• Excellent written and verbal communication skills

Who Thrives on This Team

• Are intellectually curious and seek to understand how things work
• Have a strong work ethic and drive to succeed
• Take ownership and solve problems independently
• Move quickly without sacrificing quality
• Communicate proactively and respond promptly
• Reduce others’ workload rather than add to it
• Seek feedback and stay aligned on priorities
• Work effectively as part of a team
• Approach all tasks with a team-first mindset
• Generate well-supported conclusions from complex information
• Consistently improve team effectiveness

What Success Looks Like

Successful associates anticipate needs, identify key developments early, execute reliably, and elevate team performance. They work independently, exercise sound judgment, and stay aligned with team priorities.

Equal Employment Opportunity

Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices. Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made. At Leerink Partners, we share a common desire to achieve the highest level of success for our clients. If you are passionate about healthcare and investing, our team has unmatched access to the necessary resources and support to leverage your talents and expertise into valuable contributions for our clients. Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker‑dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.